Nicolas Desbaillets

521 citations
7 papers · 392 · 1 hit paper · h-index 4

Impact in

    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • COVID-19 and healthcare impacts

Papers in

    • Cancer Immunotherapy and Biomarkers 3
    • Cancer Cells and Metastasis 1
    • CAR-T cell therapy research 1
    • Glioma Diagnosis and Treatment 1

Nicolas Desbaillets

6 papers receiving 384 citations

Nicolas Desbaillets's Hit Papers

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 2022 · 290 citations
2900+1+2Years since publication50100150200250

Peers

Nicolas Desbaillets
Comparison fields: 5 of 53
  • Infectious Diseases 227
  • Oncology 66
  • Genetics 20
  • Neurology 12
  • Toxicology 4
Replace Cheryl A. Goss with:
Cheryl A. Goss United States
Flora Eka Sari Indonesia
Heikki J Ekroos Finland
Dunia de Miguel Spain
Masoud Nazemiyeh Iran
Mariagrazia Garzia Italy
Stéphane Doucet Canada
Merna Samuel United Kingdom
Eric Lau United States
Mohammad A. Salameh United States
Nicolas Desbaillets relative to Cheryl A. Goss United States Cheryl A. Goss's profile →
Citations per field
00.5×1.5×2×
Cheryl A. Goss · 1×
Citations per year

Countries citing papers authored by Nicolas Desbaillets

Since Specialization
Citations

This map shows the geographic impact of Nicolas Desbaillets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Desbaillets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Desbaillets more than expected).

Fields of papers citing papers by Nicolas Desbaillets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Desbaillets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Desbaillets. The network helps show where Nicolas Desbaillets may publish in the future.

Co-authors

The 12 scholars most cited alongside Nicolas Desbaillets, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicolas Desbaillets Line = papers co-authored together Nicolas Desbaillets links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hit paper breakdown →
2022290
2 201963
3 202124
4 202311
5 20243
6 20151
7 20260

About Nicolas Desbaillets

Nicolas Desbaillets is a scholar working on Oncology, Genetics, Neurology, Infectious Diseases and Immunology, having authored 7 papers that have together received 392 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), COVID-19 Clinical Research Studies (1 paper), Cancer Cells and Metastasis (1 paper), Autoimmune Neurological Disorders and Treatments (1 paper), CAR-T cell therapy research (1 paper), Tuberous Sclerosis Complex Research (1 paper), Immunotherapy and Immune Responses (1 paper) and Glioma Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (227 citations), Oncology (66 citations), Genetics (20 citations), Neurology (12 citations) and Toxicology (4 citations). Nicolas Desbaillets has collaborated with scholars based in Switzerland, Germany and France. Frequent co-authors include Andreas Felix Hottinger, Pierre Dessen, Eleftheria Kampouri, Petr Szturz, Bernhard Gentner, Blanca Navarro, Vincent Dunet, Joerg Huelsken, Angela Koutsokera and Lionel Trueb. Their work appears in journals such as Cancers, The Lancet, Frontiers in Immunology, Current Opinion in Neurology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact